SQSTM1 and urinary bladder cancer: Destruction of the crosstalk between p62 and Keap1-Nrf2 pathway through inhibiting the initiation of JNK-mediated autophagy by SP600125 triggering the switch from autophagy to apoptosis, which could be utilized for sensitizing bladder cancer cells to treatment with C-2.